Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Corona Remedies was originally incorporated as ‘CORONA Remedies Private Limited’, a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli. Thereafter, the company was converted into a public limited company pursuant to a special resolution passed by its Shareholders on October 24, 2024, and consequently, the name of the company was changed to ‘CORONA Remedies Limited’. A fresh certificate of incorporation, upon conversion of the company to a public limited company was issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024.
The company is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.
The company are also focused on executing strategic brand acquisitions and establishing in-licensing arrangements to address therapy gaps in its portfolio and to establish complementary capabilities, such as backward integration, marketing arrangements, and diversified product offerings. This enables it to broaden its therapeutic presence and enhance its market position across key areas. Its customers primarily comprise pharmacies, specialty treatment facilities, other outpatient clients, physicians and hospitals. It primarily offers its products in India. It offers products across the following therapeutic areas: (i) women’s health; (ii) cardio-diabeto, (iii) pain management; (iv) urology; and (v) others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal and respiratory).
Business area of the company
The company is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products. The company also has an associate which is involved in similar line of business. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.
Products of the company
Women’s health products
Cardio-diabeto
Pain management
Urology
Others products
Awards, accreditations and recognition
History and milestones
Comment